|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM261717073 |
003 |
DE-627 |
005 |
20231224200144.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2016 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2016.06.006
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0872.xml
|
035 |
|
|
|a (DE-627)NLM261717073
|
035 |
|
|
|a (NLM)27339331
|
035 |
|
|
|a (PII)S1521-6616(16)30099-7
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Öckinger, Johan
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a T-cell activation and HLA-regulated response to smoking in the deep airways of patients with multiple sclerosis
|
264 |
|
1 |
|c 2016
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 31.03.2017
|
500 |
|
|
|a Date Revised 13.08.2017
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2016 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a Cigarette smoking is a risk factor for multiple sclerosis (MS), and the risk is further multiplied for HLA-DRB1*15(+) smokers. To define the smoke-induced immune responses in the lung we performed bronchoscopy with bronchoalveolar lavage (BAL) on smokers and non-smokers, both MS-patients and healthy volunteers. In the BAL, non-smokers with MS showed an increased preformed CD40L expression in CD4(+) T-cells while smokers displayed an increase in proliferating (Ki-67(+)) T-cells. In addition, our results confirm that smoking induces an increase of alveolar macrophages in BAL, and further defined a significant attenuation of this response in carriers of the HLA-DRB1*15 allele, in both MS patients and healthy controls. This first systematic investigation of the immune response in the lungs of smokers and non-smokers diagnosed with MS, thus suggests an MS-associated lung T-cell phenotype, involvement of a specific T-cell response to smoke, and a genetic regulation of the macrophage response
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a HLA-DRB1 Chains
|2 NLM
|
650 |
|
7 |
|a Ki-67 Antigen
|2 NLM
|
650 |
|
7 |
|a CD40 Ligand
|2 NLM
|
650 |
|
7 |
|a 147205-72-9
|2 NLM
|
700 |
1 |
|
|a Hagemann-Jensen, Michael
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kullberg, Susanna
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Engvall, Benita
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Eklund, Anders
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Grunewald, Johan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Piehl, Fredrik
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Olsson, Tomas
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wahlström, Jan
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 169(2016) vom: 28. Aug., Seite 114-120
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:169
|g year:2016
|g day:28
|g month:08
|g pages:114-120
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2016.06.006
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 169
|j 2016
|b 28
|c 08
|h 114-120
|